1. Home
  2. WVE vs NYAX Comparison

WVE vs NYAX Comparison

Compare WVE & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Nayax Ltd.

NYAX

Nayax Ltd.

N/A

Current Price

$57.50

Market Cap

2.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
NYAX
Founded
2012
2005
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
WVE
NYAX
Price
$13.35
$57.50
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
$31.47
$49.50
AVG Volume (30 Days)
2.2M
10.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
$25.96
Revenue Next Year
$119.93
$19.69
P/E Ratio
N/A
$89.78
Revenue Growth
149.43
N/A
52 Week Low
$5.28
$32.38
52 Week High
$21.73
$60.77

Technical Indicators

Market Signals
Indicator
WVE
NYAX
Relative Strength Index (RSI) 47.54 56.68
Support Level $12.53 $42.63
Resistance Level $14.56 $58.14
Average True Range (ATR) 0.79 1.56
MACD 0.01 0.48
Stochastic Oscillator 23.84 79.78

Price Performance

Historical Comparison
WVE
NYAX

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: